Israel -
hebraisk -
Ministry of Health
אקסקופרי 100 מג
dexcel ltd, israel - cenobamate - טבליות מצופות פילם - cenobamate 100 mg - cenobamate
Israel -
hebraisk -
Ministry of Health
אקסקופרי 12.5 מג
dexcel ltd, israel - cenobamate - טבליה - cenobamate 12.5 mg - cenobamate
Israel -
hebraisk -
Ministry of Health
אקסקופרי 150 מג
dexcel ltd, israel - cenobamate - טבליות מצופות פילם - cenobamate 150 mg - cenobamate
Israel -
hebraisk -
Ministry of Health
אקסקופרי 200 מג
dexcel ltd, israel - cenobamate - טבליות מצופות פילם - cenobamate 200 mg - cenobamate
Israel -
hebraisk -
Ministry of Health
אקסקופרי 25 מג
dexcel ltd, israel - cenobamate - טבליות מצופות פילם - cenobamate 25 mg - cenobamate
Israel -
hebraisk -
Ministry of Health
אקסקופרי 50 מג
dexcel ltd, israel - cenobamate - טבליות מצופות פילם - cenobamate 50 mg - cenobamate
Israel -
hebraisk -
Ministry of Health
סנדוסטטין 30 מג lar
novartis israel ltd - octreotide - אבקה וממס להכנת תרחיף להזרקה - octreotide 30 mg - octreotide - octreotide - treatment of acromegaly in: patients already adequately controlled on standard doses of sandostatin s.c. patients in whom surgery or radiotherapy are inappropriate or ineffective, or who are in the latency period before radiotherapy becomes fully effective.endocrine gastro-entero- pancreatic (gep) tumors, carcinoid tumors.
Israel -
hebraisk -
Ministry of Health
סנדוסטטין 20 מג lar
novartis israel ltd - octreotide - אבקה וממס להכנת תרחיף להזרקה - octreotide 20 mg - octreotide - octreotide - treatment of acromegaly in: patients already adequately controlled on standard doses of sandostatin s.c. patients in whom surgery or radiotherapy are inappropriate or ineffective, or who are in the latency period before radiotherapy becomes fully effective. endocrine gastro-entero- pancreatic (gep) tumors, carcinoid tumors.
Israel -
hebraisk -
Ministry of Health
סנדוסטטין 10 מג lar
novartis israel ltd - octreotide - אבקה וממס להכנת תרחיף להזרקה - octreotide 10 mg - octreotide - octreotide - treatment of acromegaly in: patients already adequately controlled on standard doses of sandostatin s.c. patients in whom surgery or radiotherapy are inappropriate or ineffective, or who are in the latency period before radiotherapy becomes fully effective. endocrine gastro-entero- pancreatic (gep) tumors, carcinoid tumors.
Israel -
hebraisk -
Ministry of Health
סיגניפור לאר 20 מג
medison pharma ltd - pasireotide as embonate - אבקה וממס להכנת תרחיף להזרקה - pasireotide as embonate 20 mg/vial - pasireotide